Rationale for off-label treatments use in primary progressive multiple sclerosis: A review of the literature
Article in Revue Neurologique (July 2022)
The most recent citing publications are shown below. View all 46 publications that cite this research output on Dimensions.
Development of antifibrotic therapy for stricturing Crohn’s disease: lessons from randomized trials in other fibrotic diseases
Article in Physiological Reviews (September 2021)
Progress in the Application of Drugs for the Treatment of Multiple Sclerosis
Article in Frontiers in Pharmacology (July 2021)